J. Chapman

发表

High b‐value q‐space analyzed diffusion‐weighted MRI: Application to multiple sclerosis

T. Hendler, S. Peled, Y. Cohen, 2002, Magnetic resonance in medicine.

Superior temporal gyrus thickness correlates with cognitive performance in multiple sclerosis

A. Achiron, J. Chapman, A. Achiron, 2012, Brain Structure and Function.

Persistence on Therapy and Propensity Matched Outcome Comparison of Two Subcutaneous Interferon Beta 1a Dosages for Multiple Sclerosis

J. Lechner-Scott, M. Slee, J. Correale, 2013, PloS one.

Guillain–Barré Syndrome—A Classical Autoimmune Disease Triggered by Infection or Vaccination

J. Chapman, Y. Shoenfeld, M. Blank, 2012, Clinical Reviews in Allergy & Immunology.

MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis

L. Kappos, D. Jolley, M. Trojano, 2006, Multiple sclerosis.

White matter changes in multiple sclerosis: correlation of q-space diffusion MRI and 1H MRS.

Talma Hendler, Yaniv Assaf, Dafna Ben-Bashat, 2005, Magnetic resonance imaging.

The Organophosphate Paraoxon and Its Antidote Obidoxime Inhibit Thrombin Activity and Affect Coagulation In Vitro

J. Chapman, N. Maggio, A. Eisenkraft, 2016, PloS one.

Complement and Coagulation System Crosstalk in Synaptic and Neural Conduction in the Central and Peripheral Nervous Systems

J. Chapman, N. Maggio, S. G. Gofrit, 2021, Biomedicines.

Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease

J. Chapman, S. Barnoy, N. Kosower, 2007, Neurochemistry International.

Antibodies To Cholinergic Cell Bodies In Alzheimer’s Disease

D. Michaelson, J. Chapman, A. Korczyn, 1986 .

The role of thrombin in the pathogenesis of diabetic neuropathy

J. Chapman, S. G. Gofrit, A. Dori, 2019, PloS one.

Focal seizures after treatment with fluvastatin in a patient with a history of catastrophic antiphospholipid syndrome

J. Chapman, W. Miesbach, I. Scharrer, 2005, Journal of the Neurological Sciences.

Passive transfer of narcolepsy: anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice.

J. Chapman, Y. Shoenfeld, Susumu Tanaka, 2013, Journal of autoimmunity.

Vasculitides—Miscellaneous Vasculitides

J. Chapman, Y. Shoenfeld, Y. Schwammenthal, 2004 .

Antiphospholipid antibodies, thrombin and LPS activate brain endothelial cells and Ras-dependent pathways through distinct mechanisms.

D. Gurwitz, J. Chapman, Y. Kloog, 2005, Immunobiology.

Aspirin Responsiveness in Acute Brain Ischaemia: Association with Stroke Severity and Clinical Outcome

D. Tanné, J. Chapman, S. Israeli-korn, 2008, Cerebrovascular Diseases.

Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil

J. Chapman, Y. Shoenfeld, M. Blank, 2017, Immunologic research.

WITHDRAWN: Behavioral abnormalities in young female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil.

J. Chapman, Y. Shoenfeld, M. Blank, 2016, Vaccine.

Apolipoprotein E4 in Parkinson Disease and Dementia: New Data and Meta‐Analysis of Published Studies

J. Chapman, A. Korczyn, R. Inzelberg, 1998, Alzheimer disease and associated disorders.

Ischemic stroke in PAR1 KO mice: Decreased brain plasmin and thrombin activity along with decreased infarct volume

J. Chapman, N. Maggio, S. G. Gofrit, 2021, PloS one.

Antineurofilament antibodies in postpolio syndrome

D. Michaelson, V. Drory, J. Chapman, 1998, Neurology.

Narcolepsy, Infections, and Autoimmunity

J. Chapman, Y. Shoenfeld, N. Agmon-Levin, 2015 .

Narcolepsy and H1N1 vaccine

J. Chapman, Y. Shoenfeld, N. Agmon-Levin, 2015 .

0488 The MSBase global web registry: joining independent local patient databases for multi-centre research

Miguel Angel Fiol, Pierre Grammond, Helmut Butzkueven, 2005, Journal of Neurological Sciences.

Increased thrombin inhibition in experimental autoimmune encephalomyelitis

D. Gurwitz, J. Chapman, A. Korczyn, 2005, Journal of neuroscience research.

Retracted: Anti-ribosomal-phosphoprotein autoantibodies penetrate to neuronal cells via neuronal growth associated protein, affecting neuronal cells in vitro.

I. Slutsky, D. Cahill, J. Chapman, 2017, Rheumatology.

Anti-ribosomal-phosphoprotein autoantibodies penetrate to neuronal cells via neuronal growth associated protein, affecting neuronal cells in vitro.

I. Slutsky, D. Cahill, J. Chapman, 2016, Rheumatology.

A Novel Compound Targeting Protease Receptor 1 Activators for the Treatment of Glioblastoma

J. Chapman, S. Harnof, Y. Mardor, 2018, Front. Neurol..

Increased brain plasmin levels following experimental ischemic stroke in male mice

J. Chapman, E. Shavit-Stein, D. Orion, 2020, Journal of neuroscience research.

Neurological Dysfunction Associated with Antiphospholipid Syndrome: Histopathological Brain Findings of Thrombotic Changes in a Mouse Model

S. Polak‐Charcon, J. Chapman, Y. Shoenfeld, 2004, Clinical & developmental immunology.

Minimal Traumatic Brain Injury in Mice: Protease-Activated Receptor 1 and Thrombin-Related Changes.

J. Chapman, S. Harnof, N. Maggio, 2016, Journal of neurotrauma.

Reversal of Trauma-Induced Amnesia in Mice by a Thrombin Receptor Antagonist

J. Chapman, N. Maggio, A. Milman, 2014, Journal of Molecular Neuroscience.

Features associated with epilepsy in the antiphospholipid syndrome.

J. Piette, J. Chapman, G. Hughes, 2004, The Journal of rheumatology.

Neuropsychiatric lupus: a mosaic of clinical presentations

J. Chapman, Y. Shoenfeld, N. Agmon-Levin, 2015, BMC Medicine.

Blocking Thrombin Significantly Ameliorates Experimental Autoimmune Neuritis

J. Chapman, S. G. Gofrit, A. Dori, 2019, Front. Neurol..

Aquaporin 4 molecular mimicry and implications for neuromyelitis optica

Radhika A. Vaishnav, J. Chapman, R. Friedland, 2013, Journal of Neuroimmunology.

Re: The apolipoprotein E epsilon4 allele increases the risk of drug-induced hallucinations in Parkinson's disease.

D. Paleacu, J. Chapman, A. Korczyn, 2000, Clinical neuropharmacology.

Apolipoprotein ɛ4 advances appearance of psychosis in patients with Parkinson's disease

A. Korczyn, J. Chapman, A. Korczyn, 2006 .

Are the ACR 2010 diagnostic criteria for fibromyalgia better than the 1990 criteria?

F. Salaffi, J. Chapman, P. Sarzi-Puttini, 2017, Autoimmunity reviews.

The Ras Antagonist, Farnesylthiosalicylic Acid (FTS), Decreases Fibrosis and Improves Muscle Strength in dy2J/dy2J Mouse Model of Muscular Dystrophy

J. Chapman, Y. Kloog, S. Reif, 2011, PloS one.

Apixaban decreases brain thrombin activity in a male mouse model of acute ischemic stroke

D. Tanné, J. Chapman, E. S. Stein, 2018, Journal of neuroscience research.

Thrombin and protein C pathway in peripheral nerve Schwann cells

J. Chapman, S. Harnof, N. Maggio, 2016, Neuroscience.

Increased thrombin activity following reperfusion after ischemic stroke alters synaptic transmission in the hippocampus

D. Tanné, J. Chapman, N. Maggio, 2015, Journal of neurochemistry.

Treating seizures and epilepsy with anticoagulants?

D. Tanné, M. Segal, J. Chapman, 2013, Front. Cell. Neurosci..

A Mutation in the Prion Protein Gene in Creutzfeldt‐Jakob Disease in Jewish Patients of Libyan, Greek, and Tunisian Origin

J. Chapman, A. Korczyn, P. Brown, 1991, Annals of the New York Academy of Sciences.

Rapidly progressive Creutzfeldt–Jakob disease in patients with Familial Mediterranean Fever

J. Chapman, I. Prohovnik, E. Pras, 2010, European journal of neurology.

Identification in Israel of 2 Jewish Creutzfeldt — Jakob disease patients with a 178 mutation at their PrP gene

J. Chapman, R. Gabizon, Y. Finkelstein, 1998, Acta neurologica Scandinavica.

Fatal insomnia in a case of familial Creutzfeldt-Jakob disease with the codon 200Lys mutation

J. Chapman, A. Korczyn, E. Werber, 1996, Neurology.

Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan origin

J. Chapman, A. Korczyn, P. Brown, 1990, The Lancet.

Immunization with cholinergic cell bodies induces histopathological changes in rat brains.

J. Feldon, D. Michaelson, J. Chapman, 1990, Molecular and chemical neuropathology.

Antibodies to Cholinergic Neurons in Alzheimer's Disease

D. Michaelson, J. Chapman, A. Korczyn, 1988, Journal of neurochemistry.

Pharmacologic management of neuropsychiatric lupus

J. Chapman, Y. Shoenfeld, S. Kivity, 2016, Expert review of clinical pharmacology.

Familial Alzheimer's disease associated with S182 codon 286 mutation

J. Chapman, A. Korczyn, T. Treves, 1995, The Lancet.

Brain Protease Activated Receptor 1 Pathway: A Therapeutic Target in the Superoxide Dismutase 1 (SOD1) Mouse Model of Amyotrophic Lateral Sclerosis

J. Chapman, Y. Kloog, N. Maggio, 2020, International journal of molecular sciences.

Apolipoprotein E and Parkinson's disease

D. Paleacu, J. Chapman, R. Inzelberg, 1998, Annals of neurology.

Evaluation of the Physiological State of White Matter by High b Value q-Space Analyzed Diffusion Weighted Imaging: Applications to Multiple Sclerosis

T. Hendler, S. Peled, Y. Cohen, 2001 .

Changes in axonal morphology in experimental autoimmune neuritis as studied by high b‐value q‐space 1H and 2H DQF diffusion magnetic resonance spectroscopy

Yaniv Assaf, Gil Navon, Yoram Cohen, 2002, Magnetic resonance in medicine.

APOE-ε4 in Patients with Alzheimer Disease and Vascular Dementia

N. Bornstein, J. Chapman, A. Korczyn, 1996 .

APOE-epsilon 4 in patients with Alzheimer disease and vascular dementia.

N. Bornstein, J. Chapman, A. Korczyn, 1996, Alzheimer disease and associated disorders.

Pruritus in Creutzfeldt-Jakob disease

J. Chapman, H. Shabtai, P. Nisipeanu, 1996, Neurology.

Coagulopathy triggered autoimmunity: experimental antiphospholipid syndrome in factor V Leiden mice

J. Chapman, Y. Shoenfeld, M. Blank, 2013, BMC Medicine.

Frequent misdiagnosis of adult polyglucosan body disease

Nir Giladi, J. Chapman, D. Kidron, 2015, Journal of Neurology.

Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome

J. Chapman, Y. Shoenfeld, M. Blank, 2005 .

Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model.

I. Barshack, J. Chapman, Y. Shoenfeld, 2014, Journal of autoimmunity.

Autoantibodies to Annexin A2 and cerebral thrombosis: Insights from a mouse model

J. Chapman, N. Agmon-Levin, I. Benhar, 2021, Lupus.

Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification.

J. Chapman, Adi Hersalis Eldar, 2014, Autoimmunity reviews.

Treatment of Diabetic Neuropathy with A Novel PAR1-Targeting Molecule

J. Chapman, S. Harnof, S. G. Gofrit, 2020, Biomolecules.

Guillain-Barré and Other Immune-Mediated Neuropathies

J. Chapman, Y. Shoenfeld, A. Unterman, 2008 .

Assessment of experimental autoimmune neuritis in the rat by electrophysiology of the tail nerve

V. Drory, J. Chapman, M. Kafri, 2002, Muscle & nerve.

Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome.

J. Chapman, Y. Shoenfeld, G. Zandman-Goddard, 2007, Seminars in arthritis and rheumatism.

Penetrance and Phenotypic Expression of a Mutation Linked to Creutzfeldt-Jakob Disease in the Elderly

J. Chapman, A. Korczyn, J. Ben-Israel, 1998, Dementia and Geriatric Cognitive Disorders.

The Strategies Used for Treatment of Experimental Autoimmune Neuritis (EAN): A Beneficial Effect of Glatiramer Acetate Administered Intraperitoneally

J. Chapman, A. Katzav, Ramona Aronovich, 2012, Clinical Reviews in Allergy & Immunology.

Epidemiological and clinical characteristics of patients with late-onset Creutzfeldt-Jakob disease

J. Chapman, E. Kahana, S. Appel, 2022, Neurological Sciences.

Human antiphospholipid antibodies induce TNFalpha in monocytes via Toll-like receptor 8.

J. Chapman, Y. Shoenfeld, K. Lackner, 2010, Immunobiology.

Inhibition of Ras attenuates the course of experimental autoimmune neuritis

V. Drory, J. Chapman, M. Kafri, 2005, Journal of Neuroimmunology.

Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome

D. Tanné, J. Chapman, Y. Shoenfeld, 2008, Neurobiology of Disease.

Antibodies to ganglioside GM1 in patients with Alzheimer's disease

D. Michaelson, J. Chapman, B. Sela, 1988, Neuroscience Letters.

Task Force Report on Brain Involvement in Antiphospholipid Syndrome

J. Chapman, E. Muscal, R. Brey, 2012 .

Brainstem auditory evoked potentials in experimental autoimmune dementia

J. Chapman, E. Werber, A. Arlazoroff, 1993, Neuroscience Letters.

Antibodies from Down's syndrome patients bind to the same cholinergic neurofilament protein recognized by Alzheimer's disease antibodies

D. Michaelson, J. Chapman, S. Hassin-Baer, 1992, Neurology.

Infections as a Cause of Guillain–Barré Syndrome

J. Chapman, Y. Shoenfeld, M. Blank, 2015 .

Retraction: Familial Alzheimer's disease associated with S182 codon 286 mutation

J. Chapman, A. Korczyn, L. Goldfarb, 1996, The Lancet.

LPS-Induced Coagulation and Neuronal Damage in a Mice Model Is Attenuated by Enoxaparin

J. Chapman, Zehavit Goldberg, N. Maggio, 2022, International journal of molecular sciences.

APOE‐ε4 in age‐related memory complaints and Alzheimer's disease

N. Bornstein, J. Chapman, A. Korczyn, 1996 .

The very high prevalence of AD in an Arab population is not explained by APOE epsilon4 allele frequency.

J. Chapman, A. Korczyn, R. Friedland, 2000, Neurology.

Intermittent rhythmic delta activity (IRDA) morphology cannot distinguish between focal and diffuse brain disturbances

J. Chapman, A. Korczyn, M. Neufeld, 1999, Journal of the Neurological Sciences.

Thrombin Inhibition Reduces the Expression of Brain Inflammation Markers upon Systemic LPS Treatment

J. Chapman, N. Maggio, Valery Golderman, 2018, Neural plasticity.

Thrombin regulation of synaptic plasticity: Implications for physiology and pathology

D. Tanné, J. Chapman, N. Amariglio, 2013, Experimental Neurology.

Thrombin regulation of synaptic transmission: Implications for seizure onset

M. Segal, C. Cavaliere, J. Chapman, 2013, Neurobiology of Disease.

Quantitative measurements of mouse brain thrombin-like and thrombin inhibition activities

D. Gurwitz, J. Chapman, A. Korczyn, 2001, Neuroreport.

Neurological and Neuroendocrine‐Cytokine Inter‐relationship in the Antiphospholipid Syndrome

J. Chapman, Y. Shoenfeld, 2002, Annals of the New York Academy of Sciences.

Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies

S. Levine, J. Chapman, Y. Shoenfeld, 2003, Lupus.

Thrombin Induces Long-Term Potentiation of Reactivity to Afferent Stimulation and Facilitates Epileptic Seizures in Rat Hippocampal Slices: Toward Understanding the Functional Consequences of Cerebrovascular Insults

M. Segal, J. Chapman, N. Maggio, 2008, The Journal of Neuroscience.

Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial

G. L. Masson, C. Ervin, H. Hartung, 2018, The Lancet Neurology.

The Effect of Neuronal Activity on Glial Thrombin Generation

J. Chapman, E. Shavit-Stein, O. Gera, 2019, Journal of Molecular Neuroscience.

The risk of developing Creutzfeldt‐Jakob disease in subjects with the PRNP gene codon 200 point mutation

J. Chapman, A. Korczyn, J. Ben-Israel, 1994, Neurology.

Diagnosis and classification of neuromyelitis optica (Devic's syndrome).

J. Chapman, T. Drori, 2014, Autoimmunity reviews.

Narcolepsy--genes, infections and vaccines: the clues for a new autoimmune disease.

J. Chapman, Y. Shoenfeld, S. Kivity, 2014, The Israel Medical Association journal : IMAJ.

Thrombin Activity and Thrombin Receptor in Rat Glioblastoma Model: Possible Markers and Targets for Intervention?

J. Chapman, S. Harnof, Y. Mardor, 2015, Journal of Molecular Neuroscience.

Thrombin and the Protease-Activated Receptor-1 in Organophosphate-Induced Status Epilepticus

J. Chapman, N. Maggio, A. Eisenkraft, 2018, Journal of Molecular Neuroscience.

Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system.

J. Chapman, Wei Zhang, Y. Shoenfeld, 2007, Arthritis and rheumatism.

Plaque morphea with neurological involvement—an extraordinary uncommon presentation

J. Chapman, Y. Shoenfeld, G. Greenberg, 2015, Clinical Rheumatology.

Creutzfeldt‐Jakob disease profile in patients homozygous for the PRNP E200K mutation

J. Chapman, A. Korczyn, E. Simon, 2000, Annals of neurology.

The Pathogenesis of Neural Injury in Animal Models of the Antiphospholipid Syndrome

J. Chapman, Y. Shoenfeld, A. Katzav, 2010, Clinical reviews in allergy & immunology.

Factor VII, EPCR, aPC Modulators: novel treatment for neuroinflammation

J. Chapman, N. Maggio, S. G. Gofrit, 2022, Journal of neuroinflammation.

Treatment for experimental autoimmune neuritis with clodronate (Bonefos)

J. Chapman, A. Katzav, Ramona Aronovich, 2013, Immunologic research.

Association of APOE epsilon4 allele with survival in amyotrophic lateral sclerosis.

V. Drory, J. Chapman, A. Korczyn, 2001, Journal of the neurological sciences.

Sarcoidosis Presenting as “Corset-like” Myelopathy: A Description of Six Cases and Literature Review

J. Chapman, Y. Levy, Z. Lidar, 2010, Clinical reviews in allergy & immunology.

Superior temporal gyrus thickness correlates with cognitive performance in multiple sclerosis

A. Achiron, J. Chapman, A. Achiron, 2013, Brain Structure and Function.

Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil

J. Chapman, Y. Shoenfeld, M. Blank, 2016, Immunologic Research.

Glatiramer Acetate Depot (extended-release) Phase IIa one-year study in patients with Relapsing-remitting Multiple Sclerosis: Safety, tolerability and efficacy – NEDA Analysis (P6.359)

J. Chapman, Ariel Miller, D. Karussis, 2018 .

Genetic Creutzfeldt‐Jakob disease in Turkish Jews—demographic and clinical features

J. Chapman, E. Kahana, R. Milo, 2022, Acta neurologica Scandinavica.

Modeling of Cognitive Impairment by Disease Duration in Multiple Sclerosis: A Cross-Sectional Study

G. Doniger, A. Achiron, J. Chapman, 2013, PloS one.

Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers.

J. Chapman, A. Korczyn, P. Kingsley, 2009, Brain : a journal of neurology.

MRI Detection of the Cerebellar Syndrome in Creutzfeldt–Jakob Disease

R. Fulbright, J. Chapman, I. Prohovnik, 2009, The Cerebellum.

Infection and vaccination in chronic fatigue syndrome: Myth or reality?

Joab Chapman, J. Chapman, Y. Shoenfeld, 2007, Autoimmunity.

Hidden function of neuronal nicotinic acetylcholine receptor β2 subunits in ganglionic transmission: comparison to α5 and β4 subunits

J. Chapman, A. Korczyn, A. Orr-Urtreger, 2005, Journal of the Neurological Sciences.

Intrinsic Expression of Coagulation Factors and Protease Activated Receptor 1 (PAR1) in Photoreceptors and Inner Retinal Layers

J. Chapman, I. Sher, Y. Rotenstreich, 2022, International journal of molecular sciences.

Abnormal olfactory function demonstrated by manganese‐enhanced MRI in mice with experimental neuropsychiatric lupus

Galia Tsarfaty, Joab Chapman, David Manor, 2010, Annals of the New York Academy of Sciences.

Nicotinic acetylcholine receptor α5 subunits modulate oxotremorine-induced salivation and tremor

J. Chapman, A. Korczyn, A. Orr-Urtreger, 2004, Journal of the Neurological Sciences.

Antibodies to prothrombin in patients with Sneddon’s syndrome

A. Korczyn, J. Chapman, S. Shavit, 1999, Neurology.

Homozygotes for oculopharyngeal muscular dystrophy have a severe form of the disease

S. Blumen, J. Bouchard, B. Brais, 1999, Annals of neurology.

Germline mutational analysis of presenilin 1 and APP genes in Jewish-Israeli individuals with familial or early-onset Alzheimer disease using denaturing gradient gel electrophoresis (DGGE)

J. Aharon-Peretz, J. Chapman, A. Korczyn, 1998, European Journal of Human Genetics.

A novel mutation of presenilin 1 in familial Alzheimer’s disease in Israel detected by denaturing gradient gel electrophoresis

J. Aharon-Peretz, J. Chapman, A. Korczyn, 1996, Human Genetics.

Neuroprotective Effect of Glatiramer Acetate on Neurofilament Light Chain Leakage and Glutamate Excess in an Animal Model of Multiple Sclerosis

J. Chapman, R. Arnon, R. Eilam, 2021, International journal of molecular sciences.

Gluten Sensitivity in Multiple Sclerosis

J. Chapman, Y. Shoenfeld, J. Anaya, 2009, Annals of the New York Academy of Sciences.

Evoked potential studies in the antiphospholipid syndrome: differential diagnosis from multiple sclerosis

V. Drory, J. Chapman, Y. Segev, 2005, Annals of the rheumatic diseases.

Thrombin regulation of synaptic transmission and plasticity: implications for health and disease

D. Tanné, J. Chapman, M. Neufeld, 2015, Front. Cell. Neurosci..

Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology

D. Michaelson, J. Chapman, A. Dori, 2020, International journal of molecular sciences.

Deficiency of nicotinic acetylcholine receptor beta 4 subunit causes autonomic cardiac and intestinal dysfunction.

J. Chapman, A. Korczyn, A. Orr-Urtreger, 2003, Molecular pharmacology.

Autonomic function in mice lacking α5 neuronal nicotinic acetylcholine receptor subunit

J. Chapman, A. Orr-Urtreger, R. Nachman, 2002, The Journal of physiology.

Head circumference and incident Alzheimer's disease: modification by apolipoprotein E.

D. Gurwitz, Abraham Weizman, J. Chapman, 2001, Neurology.

Anatomical localization of protease‐activated receptor‐1 and protease‐mediated neuroglilal crosstalk on peri‐synaptic astrocytic endfeet

D. Michaelson, J. Chapman, Efrat Shavit, 2011, Journal of neurochemistry.

Antibody-specific behavioral effects: Intracerebroventricular injection of antiphospholipid antibodies induces hyperactive behavior while anti-ribosomal-P antibodies induces depression and smell deficits in mice

J. Chapman, Y. Shoenfeld, M. Blank, 2014, Journal of Neuroimmunology.

Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS -SLE (depression).

J. Chapman, Y. Shoenfeld, M. Blank, 2008, Journal of autoimmunity.

Immunology, Autoimmunity, and Autoantibodies in Parkinson’s Disease

J. Chapman, Y. Shoenfeld, M. Blank, 2012, Clinical Reviews in Allergy & Immunology.

Thrombin induces ischemic LTP (iLTP): implications for synaptic plasticity in the acute phase of ischemic stroke

D. Tanné, J. Chapman, N. Maggio, 2015, Scientific Reports.

Pros and cons of a prion-like pathogenesis in Parkinson's disease

J. Chapman, J. Brotchie, R. Hilker, 2011, BMC neurology.

Complex syndromes of chronic pain, fatigue and cognitive impairment linked to autoimmune dysautonomia and small fiber neuropathy.

J. Chapman, Y. Shoenfeld, N. Bragazzi, 2020, Clinical immunology.

Steroid‐responsive, progressive, focal measles virus brain infection

D. Nass, J. Chapman, O. Mor, 2014, Annals of neurology.

Systemic inflammation is associated with a reduction in Synaptopodin expression in the mouse hippocampus

J. Chapman, D. Becker, N. Maggio, 2014, Experimental Neurology.

Coagulation in Inflammatory Diseases of the Central Nervous System

J. Chapman, 2013, Seminars in Thrombosis & Hemostasis.

Thrombin in inflammatory brain diseases.

J. Chapman, 2006, Autoimmunity reviews.

Thrombin receptor PAR-1 on myelin at the node of Ranvier: a new anatomy and physiology of conduction block.

D. Gurwitz, V. Drory, J. Chapman, 2008, Brain : a journal of neurology.

Autonomic dysfunction in experimental autoimmune neuritis: Heart rate

S. Viskin, J. Chapman, A. Korczyn, 2001, Journal of the Neurological Sciences.

Oculopharyngeal MD among Bukhara Jews is due to a founder (GCG)9 mutation in the PABP2 gene

S. Blumen, J. Bouchard, B. Brais, 2000, Neurology.

The impact of self-replicating proteins on inflammation, autoimmunity and neurodegeneration-An untraveled path.

J. Chapman, D. Butnaru, 2019, Autoimmunity reviews.

Tau and 14-3-3 of genetic and sporadic Creutzfeldt–Jakob disease patients in Israel

J. Chapman, A. Korczyn, Z. Meiner, 2011, Journal of Neurology.

Impaired Behavior in Young Female Mice Following Administration of Aluminum Adjuvants and the Human Papillomavirus ( HPV ) Vaccine Gardasil

J. Chapman, Y. Shoenfeld, M. Blank, 2016 .

IgG accumulates in inhibitory hippocampal neurons of experimental antiphospholipid syndrome.

J. Chapman, N. Maggio, L. Pollak, 2014, Journal of autoimmunity.

Significant Changes in the Levels of Secreted Cytokines in Brains of Experimental Antiphospholipid Syndrome Mice

J. Chapman, A. Katzav, A. Menachem, 2012, Autoimmune diseases.

Genetic and immunological factors interact in a mouse model of CNS antiphospholipid syndrome

J. Chapman, Y. Shoenfeld, M. Blank, 2006, Behavioural Brain Research.

Hyperactivity in a mouse model of the antiphospholipid syndrome

J. Chapman, A. Korczyn, Y. Shoenfeld, 2001, Lupus.

Association of APOE ε4 allele with survival in amyotrophic lateral sclerosis

V. Drory, J. Chapman, A. Korczyn, 2001, Journal of the Neurological Sciences.

Altered receptor binding densities in experimental antiphospholipid syndrome despite only moderately enhanced autoantibody levels and absence of behavioral features.

C. Sommer, J. Chapman, K. Frauenknecht, 2014, Immunobiology.

Neurological impairment in experimental antiphospholipid syndrome is associated with increased ligand binding to hippocampal and cortical serotonergic 5-HT1A receptors.

C. Sommer, J. Chapman, K. Frauenknecht, 2013, Immunobiology.

Antiphospholipid syndrome induction exacerbates a transgenic Alzheimer disease model on a female background

D. Michaelson, J. Chapman, A. Korczyn, 2011, Neurobiology of Aging.

Hyperactivity Induced by Antiphospholipid Syndrome Serum

J. Chapman, A. Katzav, A. Menachem, 2009, Annals of the New York Academy of Sciences.

Redox-reactive autoantibodies in Alzheimer's patients' cerebrospinal fluids: Preliminary studies

S. DeKosky, J. Chapman, R. Hamilton, 2007, Autoimmunity.

Mice with experimental antiphospholipid syndrome display hippocampal dysfunction and a reduction of dendritic complexity in hippocampal CA1 neurones

C. Sommer, J. Chapman, K. Frauenknecht, 2015, Neuropathology and applied neurobiology.

The interface of multiple sclerosis and antiphospholipid antibodies.

J. Chapman, 2004, Thrombosis research.

Teriflunomide normalizes anti-anxiety effect in anti-ANXA2 APS mice model teriflunomide in anti-ANXA2 mice model

J. Chapman, S. G. Gofrit, E. Shavit-Stein, 2022, Lupus.

16/6-idiotype expressing antibodies induce brain inflammation and cognitive impairment in mice: the mosaic of central nervous system involvement in lupus

J. Chapman, Y. Shoenfeld, J. Anaya, 2013, BMC Medicine.

Immunoglobulin-Mediated Neuro-Cognitive Impairment: New Data and a Comprehensive Review

J. Chapman, C. Pick, A. Katzav, 2013, Clinical Reviews in Allergy & Immunology.

Inhibition of ras by farnesylthiosalicylate significantly reduces the levels of autoantibodies in two animal models of the antiphospholipid syndrome.

J. Chapman, A. Korczyn, Y. Shoenfeld, 2003, Immunobiology.

Dementia and Antiphospholipid Antibodies

A. Mosek, J. Chapman, A. Korczyn, 2000, Dementia and Geriatric Cognitive Disorders.

Familial Creutzfeldt–Jakob disease with the E200K mutation: longitudinal neuroimaging from asymptomatic to symptomatic CJD

J. Chapman, A. Korczyn, Hedok Lee, 2015, Journal of Neurology.

CSF tau correlates with CJD disease severity and cognitive decline

J. Chapman, S. Appel, H. Rosenmann, 2016, Acta neurologica Scandinavica.

Unusual presentations in patients with E200K familial Creutzfeldt−Jakob disease

J. Chapman, C. Hoffmann, I. Kimiagar, 2016, European journal of neurology.

Early pathology in sleep studies of patients with familial Creutzfeldt–Jakob disease

J. Chapman, N. Maggio, O. Cohen, 2016, Journal of sleep research.

Characterization of sleep disorders in patients with E200K familial Creutzfeldt–Jakob disease

J. Chapman, A. Korczyn, E. Kahana, 2015, Journal of Neurology.

Preliminary evidence for anticipation in genetic E200K Creutzfeldt-Jakob disease

A. Korczyn, J. Chapman, R. Gabizon, 1999, Neurology.

Ancestral origins and worldwide distribution of the PRNP 200K mutation causing familial Creutzfeldt-Jakob disease.

P Brown, J. Long, H. Budka, 1999, American journal of human genetics.

MR Imaging of Familial Creutzfeldt-Jakob Disease: A Blinded and Controlled Study

R. Fulbright, J. Chapman, I. Prohovnik, 2008, American Journal of Neuroradiology.

The imaging appearance of Creutzfeldt-Jakob disease caused by the E200K mutation.

Peter B Kingsley, Xiaodong Guo, Isak Prohovnik, 2006, Magnetic resonance imaging.

The Creutzfeldt–Jakob disease (CJD) neurological status scale: a new tool for evaluation of disease severity and progression

J. Chapman, I. Prohovnik, Sarit Appel, 2011, Acta neurologica Scandinavica.

The EEG in E200K familial CJD: relation to MRI patterns

J. Chapman, I. Prohovnik, C. Hoffman, 2012, Journal of Neurology.

CSF tau correlates with the degree of cortical involvement in E200K familial Creutzfeldt-Jakob disease

J. Chapman, A. Korczyn, E. Kahana, 2016, Neuroscience Letters.

Clinical heterogeneity and unusual presentations of Creutzfeldt-Jakob disease in Jewish patients with the PRNP codon 200 mutation.

J. Chapman, A. Korczyn, P. Brown, 1993, Journal of neurology, neurosurgery, and psychiatry.

Genetic and environmental factors determining the development of Creutzfeldt-Jakob disease in Libyan Jews.

J. Chapman, A. Korczyn, 1991, Neuroepidemiology.

Cerebral White Matter Disruption in Creutzfeldt-Jakob Disease

J. Chapman, P. Kingsley, I. Prohovnik, 2012, American Journal of Neuroradiology.

Familial Creutzfeldt–Jakob disease homozygous to the E200K mutation: clinical characteristics and disease course

J. Chapman, A. Korczyn, E. Kahana, 2020, Journal of Neurology.

Disease duration in E200K familial Creutzfeldt–Jakob disease is correlated with clinical, radiological, and laboratory variables

J. Chapman, A. Korczyn, E. Kahana, 2018, Journal of Neural Transmission.

Pruritus in familial Creutzfeldt–Jakob disease: a common symptom associated with central nervous system pathology

Amos D. Korczyn, Joab Chapman, Chen Hoffman, 2010, Journal of Neurology.

Seizures in E200K familial and sporadic Creutzfeldt‐Jakob disease

J. Chapman, S. Appel, O. Cohen, 2015, Acta neurologica Scandinavica.

Clinical radiological correlation in E200K familial Creutzfeldt–Jakob disease

J. Chapman, A. Korczyn, E. Kahana, 2016, Journal of Neural Transmission.

Interleukin‐6 and soluble intercellular adhesion molecule‐1 in acute brain ischaemia

D. Tanné, J. Chapman, R. Schwartz, 2008, European journal of neurology.

APOE in non-Alzheimer amyloidoses

J. Chapman, A. Korczyn, P. Brown, 1998, Neurology.

TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of IL-1beta and caspase-1 in monocytes and dendritic cells.

Stefan Bauer, Joab Chapman, J. Chapman, 2009, Immunobiology.

Reduced anticardiolipin antibodies in first episode and chronic schizophrenia

J. Chapman, P. Sirota, A. Katzav, 2006, Psychiatry Research.

Anti-neuronal antibodies similar to those found in Alzheimer's disease induce memory dysfunction in rats

J. Feldon, D. Michaelson, J. Chapman, 1991, Neuroscience.

Restoring GM1 ganglioside expression ameliorates axonal outgrowth inhibition and cognitive impairments induced by blast traumatic brain injury

J. Chapman, S. Schreiber, C. Pick, 2017, Scientific Reports.

Decreased hippocampal cell proliferation in mice with experimental antiphospholipid syndrome

C. Sommer, J. Chapman, K. Frauenknecht, 2018, Brain Structure and Function.

sclerosis syndrome : differential diagnosis from multiple Evoked potential studies in the antiphospholipid

V. Drory, J. Chapman, Y. Segev, 2005 .

Reversal of Trauma-Induced Amnesia in Mice by a Thrombin Receptor Antagonist

J. Chapman, N. Maggio, A. Milman, 2014, Journal of Molecular Neuroscience.

Thrombin and the Protease-Activated Receptor-1 in Organophosphate-Induced Status Epilepticus

J. Chapman, N. Maggio, A. Eisenkraft, 2018, Journal of Molecular Neuroscience.

Recovery from trauma induced amnesia correlates with normalization of thrombin activity in the mouse hippocampus

J. Chapman, S. Harnof, N. Maggio, 2017, PloS one.

Protease Activated Receptor 2 (PAR2) Induces Long-Term Depression in the Hippocampus through Transient Receptor Potential Vanilloid 4 (TRPV4)

J. Chapman, N. Maggio, A. Vlachos, 2017, Front. Mol. Neurosci..

Novel pharmaceutical treatments for minimal traumatic brain injury and evaluation of animal models and methodologies supporting their development

N. Greig, J. Chapman, S. Schreiber, 2016, Journal of Neuroscience Methods.

Increased KPI containing amyloid precursor protein in experimental autoimmune encephalomyelitis brains

D. Gurwitz, J. Chapman, A. Korczyn, 2007, Neuroreport.

The anticoagulant activated protein C (aPC) promotes metaplasticity in the hippocampus through an EPCR‐PAR1‐S1P1 receptors dependent mechanism

D. Tanné, J. Chapman, N. Maggio, 2014, Hippocampus.

Prevalence and clinical features of dementia associated with the antiphospholipid syndrome and circulating anticoagulants

J. Chapman, A. Korczyn, R. Inzelberg, 2002, Journal of the Neurological Sciences.

Human apoE3 but not apoE4 rescues impaired astrocyte activation in apoE null mice

A. Roses, D. Michaelson, J. Chapman, 2003, Neurobiology of Disease.

Apolipoprotein E, dementia and strokes

J. Chapman, A. D. Korzcyn, 2003, Journal of the Neurological Sciences.

ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia.

N. Bornstein, J. Chapman, A. Korczyn, 1998, Stroke.

Quantitative Detection of Thrombin Activity in an Ischemic Stroke Model

D. Tanné, J. Chapman, N. Maggio, 2013, Journal of Molecular Neuroscience.

CHAPTER 6Rheumatoid Arthritis: Peripheral and Central Nervous System Involvement

J. Chapman, 2004 .

Medial plantar nerve testing facilitates identification of polyneuropathy

J. Chapman, A. Buchman, R. Schwartz, 2008, Muscle & nerve.

Ischemic stroke due to acute basilar artery occlusion: proportion and outcomes.

D. Tanné, J. Chapman, S. Israeli-korn, 2010, The Israel Medical Association journal : IMAJ.

Antibodies to brain antigens following stroke

A. Korczyn, D. Michaelson, N. Bornstein, 2001, Neurology.

The Use of Intravenous Immunoglobulin as Maintenance Therapy in Myasthenia Gravis

V. Drory, J. Chapman, A. Korczyn, 2001, Clinical neuropharmacology.

A Linear Temporal Increase in Thrombin Activity and Loss of Its Receptor in Mouse Brain following Ischemic Stroke

D. Tanné, J. Chapman, E. S. Stein, 2017, Front. Neurol..

The effects of APOE genotype on age at onset and progression of neurodegenerative diseases

D. Michaelson, J. Chapman, A. Korczyn, 2001, Neurology.

A simple and efficient method for apolipoprotein E genotype determination

J. Chapman, L. Goldfarb, J. Estupiñan, 1996, Neurology.

A Novel Highly Sensitive Method for Measuring Inflammatory Neural-Derived APC Activity in Glial Cell Lines, Mouse Brain and Human CSF

J. Chapman, N. Maggio, S. G. Gofrit, 2020, International journal of molecular sciences.

Plasma myeloperoxidase levels in acute brain ischaemia and high grade carotid stenosis

D. Tanné, J. Chapman, Y. Schwammenthal, 2020, European journal of neurology.

Apolipoprotein E ε4 Allele Does Not Influence the Development of Dementia in Parkinsonian Patients

D. Paleacu, J. Chapman, A. Korczyn, 1998 .

Alzheimer's disease antibodies bind specifically to a neurofilament protein in Torpedo cholinergic neurons

A. Korczyn, O. Bachar, D. Michaelson, 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Antibodies to human serum albumin in familial dysautonomia.

D. Michaelson, J. Chapman, C. Maayan, 1993, International archives of allergy and immunology.

Original contributions White matter changes in multiple sclerosis: correlation of q-space diffusion MRI and 1 H MRS

Talma Hendler, Yaniv Assaf, Dafna Ben-Bashat, 2005 .

Neurological Disorders

J. Chapman, T. Drori, 2019, Mosaic of Autoimmunity.

Prolonged systemic inflammation persistently modifies synaptic plasticity in the hippocampus: modulation by the stress hormones

J. Chapman, N. Maggio, A. Dori, 2013, Front. Mol. Neurosci..

Progressive Multifocal Leukoencephalopathy in Patients Treated With Chimeric Antigen Receptor T-Cells.

J. Chapman, M. Perales, M. Pasquini, 2022, Blood.

APOE genotype is a major predictor of long-term progression of disability in MS

D. Michaelson, A. Achiron, J. Chapman, 2001, Neurology.

In-thrombus thrombin secretion: a new diagnostic marker of atrial fibrillation in cryptogenic stroke

J. Chapman, A. Afek, G. Yaniv, 2020, Journal of NeuroInterventional Surgery.

Thrombin Activity and Thrombin Receptor in Rat Glioblastoma Model: Possible Markers and Targets for Intervention?

J. Chapman, S. Harnof, Y. Mardor, 2015, Journal of Molecular Neuroscience.

Web-based Multi-center Data Management System for Clinical Neuroscience Research

Joab Chapman, Hedok Lee, Alexander Pozamantir, 2010, Journal of Medical Systems.

Snord 3A: A Molecular Marker and Modulator of Prion Disease Progression

J. Chapman, R. Gabizon, E. Kahana, 2013, PloS one.

Treatment for experimental autoimmune neuritis with clodronate (Bonefos)

J. Chapman, A. Katzav, Ramona Aronovich, 2013, Immunologic Research.

Routine and quantitative EEG analysis in Gilles de la Tourette's syndrome

J. Chapman, A. Korczyn, M. Neufeld, 1990, Neurology.

The Effect of Neuronal Activity on Glial Thrombin Generation

J. Chapman, E. Shavit-Stein, O. Gera, 2019, Journal of Molecular Neuroscience.

Epidemiology of Anti-JCV Antibodies in Israeli Multiple Sclerosis Population (P02.138)

J. Chapman, A. Achiron, D. Magalashvili, 2012 .

Plasma Homocysteine Levels and Parkinson Disease: Disease Progression, Carotid Intima-media Thickness and Neuropsychiatric Complications

D. Tanné, J. Chapman, E. Vakil, 2006, Clinical neuropharmacology.

The combined treatment of Copaxone and Salirasib attenuates experimental autoimmune encephalomyelitis (EAE) in mice

Y. Assaf, J. Chapman, Y. Kloog, 2010, Journal of Neuroimmunology.

The epidemiological and clinical characteristics of patients with young-onset genetic Creutzfeldt-Jakob disease.

J. Chapman, S. Appel, O. Cohen, 2023, Neurological research.

Transmission of spongiform encephalopathy from a familial Creutzfeldt‐Jakob disease patient of Jewish Libyan origin carrying the PRNP codon 200 mutation

J. Chapman, A. Korczyn, R. Inzelberg, 1992, Neurology.

Experimental autoimmune dementia (EAD): An immunological model of memory dysfunction and Alzheimer disease

J. Feldon, D. Michaelson, J. Chapman, 1991, Journal of Neuroimmunology.

Characterization of an Experimental Autoimmune Dementia Model in the Rat

J. Feldon, D. Michaelson, J. Chapman, 1991, Annals of the New York Academy of Sciences.

Immunization of Rats With Cholinergic Neurons Induces Behavioral Deficits

J. Feldon, D. Michaelson, J. Chapman, 1989, Journal of neural transplantation.

The very high prevalence of AD in an Arab population is not explained by APOE ε4 allele frequency

J. Chapman, R. Friedland, A. Bowirrat, 2000, Neurology.

Induction of Cognitive Deficits by Immunization with Cholinergic Cell Bodies: The Influence of Age and Integrity of the Blood Brain- Barrier

D. Michaelson, J. Chapman, Gil Alroy,, 1991, Journal of basic and clinical physiology and pharmacology.

The role of apolipoprotein E polymorphisms in levodopa‐induced dyskinesia

J. Chapman, S. Hassin-Baer, A. Katzav, 2011, Acta neurologica Scandinavica.

Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes

J. Chapman, A. Korczyn, Y. Shoenfeld, 1999, Lupus.

Effectiveness of establishing a dedicated acute stroke unit in routine clinical practice in Israel.

Joab Chapman, Zeev Rotstein, D. Tanné, 2005, The Israel Medical Association journal : IMAJ.

Close association between valvular heart disease and central nervous system manifestations in antiphospholipid syndrome

J. Chapman, Y. Shoenfeld, M. Blank, 2005, Annals of the rheumatic diseases.

Identification of Histidine‐Rich Glycoprotein, a Potential Autoantigen, in Human and Rat Brain Preparations

J. Chapman, A. Korczyn, Y. Shoenfeld, 2007, Annals of the New York Academy of Sciences.

Measuring thrombin activity in frozen brain tissue

J. Chapman, S. Harnof, S. Shrot, 2017, Neuroreport.

[Prevalence of APO e4 allele in Israeli ethnic groups].

J. Chapman, A. Korczyn, O. Hilkevich, 1999, Harefuah.

Extrapyramidal signs in neurosarcoidosis versus multiple sclerosis: Is TNF alpha the link?

J. Chapman, Y. Shoenfeld, P. Langevitz, 2017, Immunobiology.

Rats immunized with cholinergic synaptosomes: A model for Lambert‐Eaton syndrome

D. Michaelson, J. Chapman, R. Rabinowitz, 1990, Muscle & nerve.

The A677V methylenetetrahydrofolate reductase gene polymorphism and carotid atherosclerosis.

N. Bornstein, J. Chapman, A. Korczyn, 1999, Stroke.

Characterization of movement disorders in patients with familial Creutzfeldt-Jakob disease carrying the E200K mutation.

J. Chapman, A. Korczyn, R. Inzelberg, 2012, The Israel Medical Association journal : IMAJ.

Close Association between valvular heart disease and central nervous system manifestations in the antiphospholipid syndrome

J. Chapman, Y. Shoenfeld, M. Blank, 2005 .

Hidden function of neuronal nicotinic acetylcholine receptor beta2 subunits in ganglionic transmission: comparison to alpha5 and beta4 subunits.

J. Chapman, A. Korczyn, A. Orr-Urtreger, 2005, Journal of Neurological Sciences.

CNS dysfunction in the antiphospholipid syndrome

J. Chapman, Y. Shoenfeld, A. Katzav, 2003, Lupus.

Monoclonal antibodies to the heavy neurofilament subunit (NF‐H) of torpedo cholinergic neurons

D. Michaelson, J. Chapman, G. Alroy, 1991, Journal of neuroscience research.

Anti-ribosomal P-protein and its role in psychiatric manifestations of systemic lupus erythematosus: myth or reality?

J. Chapman, Y. Shoenfeld, J. Chapman, 2005, Lupus.

Annexin A2, autoimmunity, anxiety and depression.

J. Chapman, I. Benhar, L. Nahary, 2016, Journal of autoimmunity.

Chronic inflammatory demyelinating polyradiculoneuropathy: revisiting the role of intravenous immmunoglobulins.

J. Chapman, Y. Shoenfeld, 2013, The Israel Medical Association journal : IMAJ.

chronic inflammatory d emyelinating Polyradiculoneuropathy: r evisiting the r ole of intravenous immmunoglobulins

J. Chapman, Y. Shoenfeld, 2013 .

Age-dependent differential expression of BACE splice variants in brain regions of tg2576 mice

D. Alkon, J. Chapman, S. Cavallaro, 2005, Neurobiology of Aging.

Absence of prion protein mutation in bipolar manic–depressive patients

R. Belmaker, M. Baron, J. Chapman, 1992, British Journal of Psychiatry.

Healthy aging and preclinical dementia: The United States–Israel Longitudinal Database Project

T. Hendler, A. Roses, Z. Khachaturian, 2010, Alzheimer's & Dementia.

Adjuvant immunization induces high levels of pathogenic antiphospholipid antibodies in genetically prone mice: another facet of the ASIA syndrome

J. Chapman, Y. Shoenfeld, S. Kivity, 2012, Lupus.

Preliminary Observations on APOE ϵ4 Allele and Progression of Disability in Multiple Sclerosis

J. Chapman, A. Korczyn, P. Nisipeanu, 1999 .

The Pathogenesis of Neural Injury in Animal Models of the Antiphospholipid Syndrome

J. Chapman, Y. Shoenfeld, A. Katzav, 2010, Clinical reviews in allergy & immunology.

Is C-reactive protein level a marker of advanced motor and neuropsychiatric complications in Parkinson’s disease?

D. Tanné, J. Chapman, E. Vakil, 2011, Journal of Neural Transmission.

Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model.

I. Barshack, J. Chapman, Y. Shoenfeld, 2014, Journal of autoimmunity.

Thrombin Activity in Rodent and Human Skin: Modified by Inflammation and Correlates with Innervation

J. Chapman, A. Dori, Valery Golderman, 2022, Biomedicines.

Mice with experimental antiphospholipid syndrome display hippocampal dysfunction and a reduction of dendritic complexity in hippocampal CA1 neurones

C. Sommer, J. Chapman, K. Frauenknecht, 2015, Neuropathology and applied neurobiology.

Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome

D. Tanné, J. Chapman, Y. Shoenfeld, 2008, Neurobiology of Disease.

Neuromylelitis Optica (Devic Syndrome)

J. Chapman, 2008 .

The association of quantitative EEG and MRI in Creutzfeldt‐Jakob Disease

J. Chapman, S. Gilat, S. Appel, 2019, Acta neurologica Scandinavica.

Decreased hippocampal cell proliferation in mice with experimental antiphospholipid syndrome

C. Sommer, J. Chapman, K. Frauenknecht, 2018, Brain Structure and Function.